Literature DB >> 26264964

Continuous neurodegeneration and death pathway activation in neurons and glia in an experimental model of severe chronic epilepsy.

Paola Nobili1, Francesca Colciaghi1, Adele Finardi1, Sara Zambon1, Denise Locatelli1, Giorgio Stefano Battaglia2.   

Abstract

Whether seizures might determine the activation of cell death pathways and what could be the relevance of seizure-induced cell death in epilepsy are still highly debated issues. We recently developed an experimental model of acquired focal cortical dysplasia (the MAM-pilocarpine or MP rat) in which the occurrence of status epilepticus--SE--and subsequent seizures induced progressive cellular/molecular abnormalities and neocortical/hippocampal atrophy. Here, we exploited the same model to verify when, where, and how cell death occurred in neurons and glia during epilepsy course. We analyzed Fluoro Jade (FJ) staining and the activation of c-Jun- and caspase-3-dependent pathways during epilepsy, from few hours post-SE up to six months of spontaneous recurrent seizures. FJ staining revealed that cell injury in MP rats was not temporally restricted to SE, but extended throughout the different epileptic stages. The region-specific pattern of FJ staining changed during epilepsy, and FJ(+) neurons became more prominent in the dorsal and ventral hippocampal CA at chronic epilepsy stages. Phospho-c-Jun- and caspase-3-dependent pathways were selectively activated respectively in neurons and glia, at early but even more conspicuously at late chronic stages. Phospho-c-Jun activation was associated with increased cytochrome-c staining, particularly at chronic stages, and the staining pattern of cytochrome-c was suggestive of its release from the mitochondria. Taken together, these data support the content that at least in the MP rat model the recurrence of seizures can also sustain cell death mechanisms, thus continuously contributing to the pathologic process triggered by the occurrence of SE.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acquired focal cortical dysplasia; Caspase-3; Cell injury; Cytochrome-c; Fluoro Jade; Phospho-c-Jun; Seizures; Status epilepticus

Mesh:

Substances:

Year:  2015        PMID: 26264964     DOI: 10.1016/j.nbd.2015.08.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  5 in total

1.  Phase-Dependent Astroglial Alterations in Li-Pilocarpine-Induced Status Epilepticus in Young Rats.

Authors:  Adriana Fernanda K Vizuete; Matheus Mittmann Hennemann; Carlos Alberto Gonçalves; Diogo Losch de Oliveira
Journal:  Neurochem Res       Date:  2017-04-25       Impact factor: 3.996

2.  A Comparison of Epileptogenic Effect of Status Epilepticus Treated With Diazepam, Midazolam, and Pentobarbital in the Mouse Pilocarpine Model of Epilepsy.

Authors:  Xiangzhen Tong; Zizhu Zhang; Jianping Zhu; Shuji Li; Shaogang Qu; Bing Qin; Yanwu Guo; Rongqing Chen
Journal:  Front Neurol       Date:  2022-05-20       Impact factor: 4.086

Review 3.  Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.

Authors:  Stjepana Kovac; Albena T Dinkova Kostova; Alexander M Herrmann; Nico Melzer; Sven G Meuth; Ali Gorji
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

4.  Calcium-/Calmodulin-Dependent Protein Kinase II (CaMKII) Inhibition Induces Learning and Memory Impairment and Apoptosis.

Authors:  Jialu Wang; Xiaoxue Xu; Wanying Jia; Dongyi Zhao; Tomasz Boczek; Qinghua Gao; Qianhui Wang; Yu Fu; Miao He; Ruixue Shi; Xin Tong; Meixuan Li; Yu Tong; Dongyu Min; Wuyang Wang; Feng Guo
Journal:  Oxid Med Cell Longev       Date:  2021-12-23       Impact factor: 6.543

5.  Ketogenic Diet Alleviates Hippocampal Neurodegeneration Possibly via ASIC1a and the Mitochondria-Mediated Apoptotic Pathway in a Rat Model of Temporal Lobe Epilepsy.

Authors:  Lijing Jia; Weiping Wang; Qi Qiao; Zhenzhen Qu; Shuang Tian; Huifang Cao; Yange Zhang; Can Sun
Journal:  Neuropsychiatr Dis Treat       Date:  2022-09-25       Impact factor: 2.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.